Laparoscopic sentinel node procedure using a combination of patent blue and radiocolloid in women with endometrial cancer

Annals of Surgical Oncology

Volumn 11, Issue 3, 2004, Pages 344-349

  Barranger, Emmanuel ^a   Cortez, Annie ^a   Grahek, Dany ^a   Callard, Patrice ^a   Uzan, Serge ^a   Darai, Emile ^a  

^a HÔPITAL TENON   (France)

Author keywords

Endometrial cancer; Laparoscopy; Patent blue; Radiocolloid; Sentinel node

Indexed keywords

CEFAZOLIN; DISULFINE BLUE; EOSIN; HEMATOXYLIN; HEPARIN; HORMONE; NANOCIS; TECHNETIUM SULFUR COLLOID TC 99M; COLORING AGENT; DIAGNOSTIC AGENT; FUCHSINE; RADIOISOTOPE;

ADULT; AGED; ANAPHYLAXIS; ARTICLE; CANCER STAGING; CELL ISOLATION; CLINICAL ARTICLE; ENDOMETRIUM CANCER; FEASIBILITY STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; IMMUNOHISTOCHEMISTRY; LAPAROSCOPIC SURGERY; LYMPH NODE METASTASIS; PELVIS LYMPHADENECTOMY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; RADICAL HYSTERECTOMY; SENTINEL LYMPH NODE; STAINING; TUMOR CELL; CARCINOMA; CLINICAL TRIAL; COLLOID; ENDOMETRIUM TUMOR; LAPAROSCOPY; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

AGED; CARCINOMA; COLLOIDS; COLORING AGENTS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LAPAROSCOPY; LYMPHATIC METASTASIS; MIDDLE AGED; RADIOISOTOPES; ROSANILINE DYES; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 2442644309     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2004.07.005     Document Type: Article

References (35)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36.
2. Annual report on the results of treatment in gynecologic cancer. Int J Gynaecol Obstet 1989;28:189-90.
3. Disaia PJ, Creasman WT, Boronow RC, Blessing JA. Risk factors and recurrent patterns in stage I endometrial cancer. Am J Obstet Gynecol 1985;151:1009-15.
4. American Joint Committee on Cancer. Manual for Staging of Cancer. 4th ed. Philadelphia: Lippincott, 1992:155-7.
5. Masubuchi S, Fujimoto I, Masubuchi K. Lymph node metastasis and prognosis of endometrial carcinoma. Gynecol Oncol 1979;7:36-46.
6. Figge DC, Otto PM, Tamimi HK, Greer BE. Treatment variables in the management of endometrial cancer. Am J Obstet Gynecol 1983;146:495-500.
7. Boronow RC, Morrow CP, Creasman WT, et al. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol 1984;63:825-32.
8. Descamps P, Calais G, Vitu L, Body G, Lansac J. Stage I and II endometrial adenocarcinomas. Prognostic value of lymph node invasion (in French). J Gynecol Obstet Biol Reprod 1991;20:223-9.
9. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study. Cancer 1987;60(8 Suppl):2035-41.
10. Wallin TE, Malkasian GDJ, Gaffey TA, O'Brien PC, Fountain KS. Stage II cancer of the endometrium: a pathologic and clinical study. Gynecol Oncol 1984;18:1-17.
11. Corn BW, Lanciano RM, Greven KM, et al. Impact of improved irradiation technique, age, and lymph node sampling on the severe complication rate of surgically staged endometrial cancer patients: a multivariate analysis. J Clin Oncol 1994;12:510-5.
12. Arduino S, Leo L, Febo G, Tessarolo M, Wierdis T, Lanza A. Complications of pelvic and para-aortic lymphadenectomy in patients with endometrial cancer. Eur J Gynaecol Oncol 1997;18:208-10.
13. Gould EA, Winship T, Philbin PH, Kerr H. Observations on a "sentinel node" in the parotid. Cancer 1960;13:77-8.
14. Levenback C, Burke TW, Gershenson DM, Morris M, Malpica A, Ross MI. Intraoperative lymphatic mapping for vulvar cancer. Obstet Gynecol 1994;84:163-7.
15. De Hullu JA, Hollema H, Piers DA, et al. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol 2000;18:2811-6.
16. Levenback C, Coleman RL, Burke TW, Bodurka-Bevers D, Wolf JK, Gershenson DM. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol 2001;83:276-81.
17. O'Boyle JD, Coleman RL, Bernstein SG, Lifshitz S, Muller CY, Miller DS. Intraoperative lymphatic mapping in cervix cancer patients undergoing radical hysterectomy: a pilot study. Gynecol Oncol 2000;79:238-43.
18. Dargent D, Martin X, Mathevet P. Laparoscopic assessment of the sentinel lymph node in early stage cervical cancer. Gynecol Oncol 2000;79:411-5.
19. Levenback C, Coleman RL, Burke TW, et al. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol 2002;20:688-93.
20. Verheijen RH, Pijpers R, van Diest PJ, Burger CW, Buist MR, Kenemans P. Sentinel node detection in cervical cancer. Obstet Gynecol 2000;96:135-8.
21. Lantzsch T, Wolters M, Grimm J, et al. Sentinel node procedure in Ib cervical cancer: a preliminary series. Br J Cancer 2001;85:791-4.
22. Barranger E, Grahek D, Cortez A, Uzan S, Darai E. Laparoscopic sentinel node procedure in patients with cervical cancer. J Clin Oncol 2002;20:2602-3.
23. Barranger E, Grahek D, Cortez A, Talbot JN, Uzan S, Darai E. Laparoscopic sentinel lymph node procedure using a combination of patent blue and radioisotope in women with cervical carcinoma. Cancer 2003;97:3003-9.
24. Burke TW, Levenback C, Tornos C, Morris M, Wharton JT, Gerhenson D. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in patients with high risk endometrial cancer: results of a pilot study. Gynecol Oncol 1996;62:169-73.
25. Echt ML, Finan MA, Hoffman MS, Kline RC, Roberts WS, Fiorica JV. Detection of sentinel lymph nodes with lymphazurin in cervical, uterine, and vulvar malignancies. South Med J 1999;92:204-8.
26. Holub Z, Jabor A, Kliment L. Comparison of two procedures for sentinel lymph node detection in patients with endometrial cancer: a pilot study. Eur J Gynaecol Oncol 2002;1:53-7.
27. 99mTc colloid and blue dye in patients with endometrial cancer. Tumori 2002;88:S9-10.
28. Bremond A, Bataillard A, Thomas L, et al. Cancer of the endometrium. Br J Cancer 2001;84(Suppl 2):31-6.
29. Leveuf J, Godard H. Lymphatic drainage of the uterus (in French). Rev Chir 1923;61:219-48.
30. Lecuru F, Neji K, Robin F, Darles C, de Bièvre P, Taurelle R. Lymphatic drainage of the uterus: preliminary results of an experimental study (in French). J Gynecol Obstet Biol Reprod 1997;26:418-23.
31. Flanagan CW, Mannel RS, Walker JL. Johnson GA. Incidence and location of para-aortic lymph node metastases in gynecologic malignancies. J Am Coll Surg 1995;181:72-4.
32. Mariani A, Webb MJ, Keeney GL, Pdratz KC. Routes of lymphatic spread: a study of 112 consecutive patients with endometrial cancer. Gynecol Oncol 2001;81:100-4.
33. Michel G, Morice P, Castaigne D, Leblanc M, Rey A, Duvillard P. Lymphatic spread in stage Ib and II cervical carcinoma: anatomy and surgical implications. Obstet Gynecol 1998;91:360-3.
34. Stitzenberg KB, Calvo BF, Iacocca MV, et al. Cytokeratin immunohistochemical validation of the sentinel node hypothesis in patients with breast cancer. Am J Clin Puthol 2002;117:729-37.
35. Yabushita H, Shimazu M, Yamada H, Sawaguchi K, Nogushi M, Nakanishi M. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. Gynecol Oncol 2001;80:139-44.